Literature DB >> 16814239

A combination solution for routine pupillary dilation.

David M Krumholz1, Joan K Portello, Mark Rosenfield, Jacob D Rosenbaum.   

Abstract

BACKGROUND: This study investigated the ability of a combination drop containing reduced concentrations of tropicamide and phenylephrine to produce pupillary dilation adequate for routine fundoscopy.
METHODS: One eye of each subject (N = 28; age range, 21 to 40 years; median, 23 years) was dilated with 1 drop of a solution containing 0.5% tropicamide and 2.5% phenylephrine (0.5T/2.5P). The other eye was dilated with 1 drop of either of 2 mixtures: 0.5% tropicamide and 1.25% phenylephrine (0.5T/1.25P, N = 15; median age, 23 years), or 0.25% tropicamide and 1.25% phenylephrine (0.25T/1.25P, N = 13; median age, 23 years). A topical anesthetic was administered before instilling the mydriatic agents. Pupil diameter was measured from a flash photograph taken every 15 minutes for 3 hours. There was no significant difference in pupil diameter between eyes dilated with the 0.5T/1.25P test solution and the 0.5T/2.5P control solution for the first 75 minutes after instillation (P = 0.41). All pupils reached their maximum diameter 60 minutes after drop instillation; where no significant difference was observed between the 3 mydriatic solutions (P = 0.81). All pupils were at least 7 mm in diameter 30 minutes after drop instillation, and this size was maintained for at least another 75 minutes for all solutions.
CONCLUSIONS: Combination preparations of reduced concentrations of tropicamide and phenylephrine can produce clinically adequate mydriasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814239     DOI: 10.1016/j.optm.2006.04.107

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  6 in total

1.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

2.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

3.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

4.  The comparison of mydriatic effect between two drugs of different mechanism.

Authors:  Ji-Hyun Park; Young-Chun Lee; Se-Youp Lee
Journal:  Korean J Ophthalmol       Date:  2009-03-09

5.  Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial.

Authors:  Adisak Trinavarat; Auengporn Pituksung
Journal:  Indian J Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 1.848

6.  Assessing the Clinical Requirement of 2.5% Phenylephrine for Diagnostic Pupil Examination.

Authors:  Junsang Cho; Brent Bruck; James C Liu; Susan M Culican
Journal:  J Ocul Pharmacol Ther       Date:  2021-03-08       Impact factor: 2.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.